1. Cytomegalovirus and Schizophrenia

   • E. Fuller Torrey
   • Markus F. Leweke
   • Robert H. Yolken

   Current Opinion 29 August 2012 Pages: 879 - 885

   

2. Development of CRF₁ Receptor Antagonists as Antidepressants and Anxiolytics

   • Glenn R. Valdez

   Leading Article 29 August 2012 Pages: 887 - 896

   

3. Psychiatric Manifestations of Graves’ Hyperthyroidism

   • Robertas Bunevicius
   • Arthur J. Prange Jr

   Therapy In Practice 29 August 2012 Pages: 897 - 909

   

4. Epilepsy with Myoclonic Absences

   • Pierre Genton
   • Michelle Bureau

   Review Article 29 August 2012 Pages: 911 - 916

   

5. Neuraxial Drug Administration

   • Stephan A. Schug
   • David Saunders
   • Michael J. Paech

   Review Article 29 August 2012 Pages: 917 - 933

   

6. A Naturalistic Study of Galantamine for Alzheimer’s Disease

   • Henry Brodaty
   • Michael Woodward
   • Gabrielle Allen

   Original Research Article 29 August 2012 Pages: 935 - 943

   

7. Varenicline

   • Gillian M. Keating
   • M. Asif A. Siddiqui

   Adis Drug Evaluation 29 August 2012 Pages: 945 - 960

   

8. Spotlight on Eletriptan in Migraine

   • Paul L. McCormack
   • Gillian M. Keating

   Adis Spotlight 29 August 2012 Pages: 961 - 964